|
À̳뿡ÀÌÄ¡¾ËÄÁ¼³Æà |
[±¹³»À¯¸íÁ¦¾àȸ»ç] CPL(Clinical Project Leader) ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.15 |
|
|
À̳뿡ÀÌÄ¡¾ËÄÁ¼³Æà |
[¿Ü±¹°èÁ¦¾àȸ»ç] Medical Doctor ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
06.15 |
|
|
À̳뿡ÀÌÄ¡¾ËÄÁ¼³Æà |
[¿Ü±¹°èÁ¦¾àȸ»ç] CRA ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
06.15 |
|
|
(ÁÖ)¿ø³×½º¿¡ÀÌÄ¡¾Ë |
À¯¸íÁ¦¾à-CRA´ã´ç ´ë¸®-°úÀå±Þ ( ÀÇ»ç,¾à»ç,°£È£»ç )
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
07.07 |
|
|
ÇÒ¾¾¾ð½áÄ¡ |
Senior CRA
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
03.09 |
|
|
È޸չ븮 |
ÀÓ»ó ½ºÆä¼È¸®½ºÆ®
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.03 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆÄ·º¼¿ ÄÚ¸®¾Æ - Clinical Lead
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
09.13 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ -CRA
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
09.13 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ -CRA
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.10 |
|
|
(ÁÖ)¾¾¾Ø¿¡½ºÄÚ¸®¾Æ |
CRA °æ·Â»ç¿ø ä¿ë/ ¿Ü±¹°è Á¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
02.18 |
|
|
(ÁÖ)¿¡À̽ºÆ÷Áö¼ÇÄÁ¼³Æà |
±¹³» Á¦¾à»ç Á¦Á¦ ¿¬±¸ Àü¹®°¡
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
10³â¡è |
ä¿ë½Ã |
04.27 |
|
|
A&T Consulting |
Clinical Research Associate
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
10.10 |
|
|
¾ÆÀÌÄÜŬ¸®´ÏÄø®¼Ä¡ |
Global CRO ICON Korea CRA II / Sr. Contract & Grant Anal
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
¿¥¾ÆÀ̾ËȦµù½º |
¼¿ï µ¿ÀÛ±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
12.23 |
|
|
(ÁÖ)¹Ì½Ã°£ÄÁ¼³Æà |
À¯·´°èÁ¦¾à±â¾÷ CRA½ÅÀÔ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
½ÅÀÔ |
ä¿ë½Ã |
01.17 |
|